BRPI0709847B8 - composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio - Google Patents
composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcioInfo
- Publication number
- BRPI0709847B8 BRPI0709847B8 BRPI0709847A BRPI0709847A BRPI0709847B8 BR PI0709847 B8 BRPI0709847 B8 BR PI0709847B8 BR PI0709847 A BRPI0709847 A BR PI0709847A BR PI0709847 A BRPI0709847 A BR PI0709847A BR PI0709847 B8 BRPI0709847 B8 BR PI0709847B8
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- calcium carbonate
- fast
- composition containing
- solid pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0607085.8A GB0607085D0 (en) | 2006-04-07 | 2006-04-07 | Novel compositions |
GB0607085.8 | 2006-04-07 | ||
PCT/US2007/065829 WO2007118063A1 (en) | 2006-04-07 | 2007-04-03 | Fast release paracetamol tablets |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0709847A2 BRPI0709847A2 (pt) | 2011-07-26 |
BRPI0709847B1 BRPI0709847B1 (pt) | 2020-09-15 |
BRPI0709847B8 true BRPI0709847B8 (pt) | 2021-05-25 |
Family
ID=36539581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0709847A BRPI0709847B8 (pt) | 2006-04-07 | 2007-04-03 | composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio |
Country Status (15)
Country | Link |
---|---|
US (1) | US8461210B2 (pt) |
EP (1) | EP2010159B1 (pt) |
CN (1) | CN101466359B (pt) |
AU (1) | AU2007234864B2 (pt) |
BR (1) | BRPI0709847B8 (pt) |
CA (1) | CA2648725A1 (pt) |
CR (1) | CR10349A (pt) |
DK (1) | DK2010159T3 (pt) |
EA (1) | EA017157B1 (pt) |
GB (1) | GB0607085D0 (pt) |
MX (1) | MX2008012731A (pt) |
MY (1) | MY147641A (pt) |
NO (1) | NO20084065L (pt) |
NZ (1) | NZ571624A (pt) |
WO (1) | WO2007118063A1 (pt) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0813929D0 (en) * | 2008-07-30 | 2008-09-03 | Glaxo Group Ltd | Novel method |
MY150626A (en) | 2009-10-30 | 2014-02-07 | Ix Biopharma Ltd | Fast dissolving solid dosage form |
US20130108699A1 (en) * | 2010-04-26 | 2013-05-02 | Jose Antonio Matji Tuduri | Highly dispersible granulate for the preparation of formulations of high dosage active substances and procedure for obtaining high dosage active substances thereof |
US9446000B2 (en) * | 2011-09-08 | 2016-09-20 | Masdar Institute Of Science And Technology | Cellulosic gel material as a pharmaceutical excipient |
US20140128415A1 (en) * | 2012-05-30 | 2014-05-08 | Paul Daniel Yered | Excipient drug composition |
CN103110637B (zh) * | 2013-02-19 | 2014-07-30 | 青岛正大海尔制药有限公司 | 酚咖胶囊及其制备方法 |
BE1021194B1 (nl) * | 2014-07-07 | 2015-07-14 | Nordic Specialty Pharma Bvba | Paracetamol tabletten |
CN105310990B (zh) * | 2014-12-04 | 2018-01-19 | 蚌埠丰原涂山制药有限公司 | 一种防止粘冲和裂片的对乙酰氨酚片及其制备方法 |
BE1023116B1 (nl) * | 2015-07-24 | 2016-11-23 | Nordic Specialty Pharma Bvba | Paracetamol omvattend preparaat met vertraagde en aanhoudende afgifte |
CN105055329A (zh) * | 2015-08-05 | 2015-11-18 | 安丘市鲁安药业有限责任公司 | 复合扑热息痛速溶颗粒及其制备方法 |
CN106265573A (zh) * | 2016-09-23 | 2017-01-04 | 广东岭南职业技术学院 | 一种扑热息痛片生产中hpmc浆的制备工艺 |
CN108451916B (zh) * | 2018-06-19 | 2020-08-14 | 重庆国泰康宁制药有限责任公司 | 一种对乙酰氨基酚药物组合物制剂及其制备方法 |
CN108853038A (zh) * | 2018-08-06 | 2018-11-23 | 成都通德药业有限公司 | 一种对乙酰氨基酚片及其制备工艺 |
CN111374953A (zh) * | 2018-12-31 | 2020-07-07 | 上海鼎雅药物化学科技有限公司 | 对乙酰氨基酚片及其制备工艺 |
EP3679926A1 (en) * | 2019-01-14 | 2020-07-15 | APTYS Pharmaceuticals SAS | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby |
CN110101672A (zh) * | 2019-05-07 | 2019-08-09 | 安徽金太阳生化药业有限公司 | 一种对乙酰氨基酚片及其制备方法 |
CN111012750A (zh) * | 2019-12-27 | 2020-04-17 | 北京济美堂医药研究有限公司 | 一种对乙酰氨基酚片及其制备方法 |
GB202007670D0 (en) * | 2020-05-22 | 2020-07-08 | Glaxosmithkline Consumer Healthcare Holdings Us Llc | Pharmaceutical composition |
CN114129524A (zh) * | 2021-09-30 | 2022-03-04 | 山东齐都药业有限公司 | 对乙酰氨基酚片剂及其制备方法 |
CN114432256A (zh) * | 2021-12-31 | 2022-05-06 | 陕西必康制药集团控股有限公司 | 对乙酰氨基酚包衣片及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1182049A (en) | 1981-07-13 | 1985-02-05 | Francis J. Sterbenz | Apap antacid composition |
CA2009326C (en) | 1989-05-09 | 1998-01-27 | Lawrence J. Daher | Aqueous granulation solution and a method of tablet granulation |
CA2021548A1 (en) * | 1989-09-01 | 1991-03-02 | Ronald Nash Duvall | Effervescent cold or sinus allergy medicine composition having reduced sodium content |
GB9704524D0 (en) | 1997-03-05 | 1997-04-23 | Smithkline Beecham Plc | Composition |
GB0114069D0 (en) | 2001-06-08 | 2001-08-01 | Smithkline Beecham Plc | Composition |
US8216610B2 (en) | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
US20080287456A1 (en) | 2004-05-28 | 2008-11-20 | Imaginot Pty Ltd | Oral Therapeutic Compound Delivery System |
JP2008500287A (ja) | 2004-05-28 | 2008-01-10 | イメイジノット ピーティーワイ エルティーディー | 経口供給系 |
RU2398571C2 (ru) | 2004-10-28 | 2010-09-10 | Новартис Аг | Композиция, включающая ацетаминофен, кофеин и необязательно аспирин в смеси со щелочным агентом для увеличения абсорбции |
JP2009517346A (ja) | 2005-11-28 | 2009-04-30 | イメイジノット ピーティーワイ エルティーディー | 治療用化合物の経口送達系 |
-
2006
- 2006-04-07 GB GBGB0607085.8A patent/GB0607085D0/en not_active Ceased
-
2007
- 2007-04-03 WO PCT/US2007/065829 patent/WO2007118063A1/en active Application Filing
- 2007-04-03 NZ NZ571624A patent/NZ571624A/en unknown
- 2007-04-03 CN CN2007800211049A patent/CN101466359B/zh active Active
- 2007-04-03 EP EP07759996A patent/EP2010159B1/en active Active
- 2007-04-03 MX MX2008012731A patent/MX2008012731A/es active IP Right Grant
- 2007-04-03 US US12/295,941 patent/US8461210B2/en active Active
- 2007-04-03 CA CA002648725A patent/CA2648725A1/en not_active Abandoned
- 2007-04-03 BR BRPI0709847A patent/BRPI0709847B8/pt active IP Right Grant
- 2007-04-03 AU AU2007234864A patent/AU2007234864B2/en active Active
- 2007-04-03 DK DK07759996.7T patent/DK2010159T3/da active
- 2007-04-03 EA EA200801926A patent/EA017157B1/ru not_active IP Right Cessation
-
2008
- 2008-09-24 NO NO20084065A patent/NO20084065L/no unknown
- 2008-10-03 MY MYPI20083952A patent/MY147641A/en unknown
- 2008-10-07 CR CR10349A patent/CR10349A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2648725A1 (en) | 2007-10-18 |
MY147641A (en) | 2012-12-31 |
EA200801926A1 (ru) | 2009-04-28 |
CN101466359A (zh) | 2009-06-24 |
AU2007234864B2 (en) | 2012-11-22 |
GB0607085D0 (en) | 2006-05-17 |
AU2007234864A1 (en) | 2007-10-18 |
CN101466359B (zh) | 2013-09-25 |
EP2010159B1 (en) | 2012-08-22 |
MX2008012731A (es) | 2008-10-14 |
CR10349A (es) | 2008-11-26 |
DK2010159T3 (da) | 2012-10-22 |
US8461210B2 (en) | 2013-06-11 |
US20090170955A1 (en) | 2009-07-02 |
NO20084065L (no) | 2008-10-30 |
EP2010159A1 (en) | 2009-01-07 |
BRPI0709847A2 (pt) | 2011-07-26 |
EA017157B1 (ru) | 2012-10-30 |
BRPI0709847B1 (pt) | 2020-09-15 |
NZ571624A (en) | 2011-11-25 |
WO2007118063A1 (en) | 2007-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0709847B8 (pt) | composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio | |
CL2007003356A1 (es) | Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades. | |
MX2009004203A (es) | Combinaciones de paracetamol/ibuprofeno y metodo para su uso. | |
ECSP088239A (es) | Composición de liberación de fármaco sostenida | |
CL2018001420A1 (es) | Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma. (divisional solicitud 201701853) | |
PE20061091A1 (es) | FORMA CRISTALINA BETA-d DEL CLORHIDRATO DE IVABRANDINA, SU PROCEDIMIENTO DE PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN | |
AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
MX2010007609A (es) | Formulacion de capsula. | |
BR112014018378A8 (pt) | Processo contínuo para a preparação de um comprimido compreendendo ácido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol5-il) ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico | |
WO2008146178A3 (en) | A novel tablet dosage form | |
BRPI0606883A2 (pt) | composição farmacêutica para administração oral, método para preparar um tablete, e, forma de dosagem sólida única | |
UY29086A1 (es) | Nuevas composiciones farmacéuticas para el tratamiento de trastornos hiperproliferativos. | |
BRPI0906181A2 (pt) | "método para tratamento de uma disfunção hiperproliferativa, composição farmacêutica, uso de uma combinação terapêutica na fabricação de um medicamento para o tratamento de câncer, artigo de fabricação para tratamento de uma disfunção hiperproliferativa, método para determinação de compostos a serem usados em combinação para o tratamento de câncer e método para determinação de uma combinação terapêutica a ser usada para o tratamento de câncer" | |
BR112012023324B8 (pt) | processo de preparação de uma forma de dosagem multifásica liofilizada de dissolução rápida | |
MX2009003184A (es) | Composiciones farmaceuticas que comprenden nilotinib o su sal. | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
IL181445A0 (en) | Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium selective modulators | |
AR034900A1 (es) | Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica | |
MX2010007083A (es) | Combinacion anti-retroviral. | |
CO6640264A2 (es) | Combinación de gránulos cargados activos con activos adicionales | |
MX2009004017A (es) | Usos de los compuestos carboxi-amido triazol y sus sales. | |
CL2007001838A1 (es) | Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih. | |
CL2004000899A1 (es) | Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion. | |
BG109430A (en) | FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION | |
AR095159A2 (es) | Una composición farmacéutica en forma de cápsula para administración oral |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: GLAXOSMITHKLINE LLC (US) |
|
B25G | Requested change of headquarter approved |
Owner name: GLAXOSMITHKLINE DUNGARVAN LIMITED (IE) |
|
B25A | Requested transfer of rights approved |
Owner name: GLAXOSMITHKLINE DUNGARVAN LIMITED (IE) |
|
B25A | Requested transfer of rights approved |
Owner name: GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (I |
|
B25D | Requested change of name of applicant approved |
Owner name: GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (I |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/09/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25D | Requested change of name of applicant approved |
Owner name: GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) (NO. 2) UNLIMITED COMPANY (IE) |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/04/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B25A | Requested transfer of rights approved |
Owner name: GLAXOSMITHKLINE CONSUMER HEALTHCARE (UK) IP LIMITED (GB) |